Encyclopedia of Couple and Family Therapy

Living Edition
| Editors: Jay Lebow, Anthony Chambers, Douglas C. Breunlin

Adjunctive Psychopharmacology in Couple and Family Therapy

Living reference work entry
DOI: https://doi.org/10.1007/978-3-319-15877-8_421-1

Introduction

This entry reviews five major categories of psychopharmacological medications used to treat mood disorders, anxiety disorders, bipolar disorders, psychotic disorders, and attention-deficit/hyperactivity disorder. The term adjunctive distinguishes how therapists should approach medication. Medication should be viewed as supplemental. Only one role of the therapist is as medication manager with tasks like identifying target symptoms to treat with medications, assessing medication responsiveness, confirming use as directed, coping with side effects, and working with the prescribing physician.

Theoretical Framework

The systemic perspective notes multiple influences on the client. Therapists treat the whole family to use relationships to heal. Working with the family provides the best support for the individual using psychotropic medication. Yet, the medical model should be incorporated into therapy to ensure the client is receiving the best standard of care. For example,...

Keywords

Bipolar Disorder Depressive Episode ADHD Symptom Psychotropic Medication Family Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access

References

  1. DeSousa, A., & Kalra, G. (2012). Drug therapy of attention deficit hyperactivity disorder: Current trends. Mens Sana Monigraphs, 10, 45–69.CrossRefGoogle Scholar
  2. Girardi, P., Brugnoli, R., Manfredi, G., & Sani, G. (2016). Lithium in bipolar disorder: Optimizing therapy using prolonged-release formulations. Drugs in R&D, 16, 293–302.CrossRefGoogle Scholar
  3. Mancini, K., & Luebbe, A. (2016). Dyadic affective flexibility and emotional inertia in relation to youth psychopathology: An integrated model at two timescales. Clinical Child and Family Psychology Review, 19, 117–133.CrossRefPubMedGoogle Scholar
  4. McIntosh, A., Cohen, A., Turnbull, N. et al. (2004). Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder. National Collaborating Centre for Primary Care.Google Scholar
  5. Meyer, D. (2014). Candidates for Antidepressants: Assessing a history of early life stressors CounselingVistas. Retrieved from http://www.counseling.org/docs/default-source/vistas/article_65.pdf?Sfvrsn=8
  6. Nicolas, G., Desilva, A., Prater, K., & Bronkoski, E. (2009). Empathic family stress as a sign of family connectedness in Haitian immigrants. Family Process, 48, 135–150.CrossRefPubMedGoogle Scholar
  7. Olfson, M., King, M., & Schoenbaum, M. (2015). Benzodiazepine use in the United States. JAMA Psychiatry, 72, 136–142.CrossRefPubMedGoogle Scholar
  8. Poon, S., Sim, K., & Baldessarini, R. (2015). Pharmacological approaches for treatment-resistant bipolar disorder. Current Neuropharmacology, 13, 592–604.CrossRefPubMedCentralGoogle Scholar
  9. Smith, T., Weston, C., & Lieberman, J. (2010). Schizophrenia (maintenance treatment). American Family Physician, 82, 338–339.PubMedGoogle Scholar
  10. Weitz, E., Hollon, S., Twisk, J., et al. (2015). Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs. pharmacotherapy: An individual patient data meta-analysis. JAMA Psychiatry, 72, 1102–1109.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.St. Louis UniversitySt. LouisUSA